ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Liposomes Drug Delivery Market Report & Forecast 2023-2029
Published Date: 2023-11-29
|
Report Code: QYRE-Auto-26S15744
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Liposomes Drug Delivery Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Liposomes Drug Delivery Market Report & Forecast 2023-2029

Code: QYRE-Auto-26S15744
Report
2023-11-29
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Carrier
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia

and India Liposomes Drug Delivery Market Size

The global Liposomes Drug Delivery revenue was US$ 3335.2 million in 2022 and is forecast to a readjusted size of US$ 6549.6 million by 2029 with a CAGR of 10.0% during the forecast period (2023-2029).

and India Liposomes Drug Delivery Market

and India Liposomes Drug Delivery Market

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
In India, the Liposomes Drug Delivery revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
This report focuses on global and India Liposomes Drug Delivery market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Liposomes Drug Delivery will continue to grow rapidly in the future.
Global Liposomes Drug Delivery Scope and Market Size
Liposomes Drug Delivery market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Liposomes Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Liposomes Drug Delivery market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Liposomes Drug Delivery Market Report

Report Metric Details
Report Name and India Liposomes Drug Delivery Market
Forecasted market size in 2029 US$ 6549.6 million
CAGR 10.0%
Forecasted years 2023 - 2029
Segment by Type
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
Segment by Application
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical, CSPC, Novartis, Kingond Pharm, Spectrum Pharmaceuticals, Shanghai New Asia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Liposomes Drug Delivery Market size in 2029?

Ans: The and India Liposomes Drug Delivery Market size in 2029 will be US$ 6549.6 million.

What is the and India Liposomes Drug Delivery Market share by region?

Ans: Following North America, Europe is the second largest market with market share of 36%. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the market share of major companies in and India Liposomes Drug Delivery Market?

Ans: Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.

Who are the main players in the and India Liposomes Drug Delivery Market report?

Ans: The main players in the and India Liposomes Drug Delivery Market are Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical, CSPC, Novartis, Kingond Pharm, Spectrum Pharmaceuticals, Shanghai New Asia

What are the Application segmentation covered in the and India Liposomes Drug Delivery Market report?

Ans: The Applications covered in the and India Liposomes Drug Delivery Market report are Fungal Infection Therapy, Cancer & Tumor Therapy, Others

What are the Type segmentation covered in the and India Liposomes Drug Delivery Market report?

Ans: The Types covered in the and India Liposomes Drug Delivery Market report are Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others

1 Study Coverage
1.1 Liposomes Drug Delivery Product Introduction
1.2 Global Liposomes Drug Delivery Outlook 2018 VS 2022 VS 2029
1.2.1 Global Liposomes Drug Delivery Sales in US$ Million for the Year 2018-2029
1.2.2 Global Liposomes Drug Delivery Sales in Volume for the Year 2018-2029
1.3 India Liposomes Drug Delivery Outlook 2018 VS 2022 VS 2029
1.3.1 India Liposomes Drug Delivery Sales in US$ Million for the Year 2018-2029
1.3.2 India Liposomes Drug Delivery Sales in Volume for the Year 2018-2029
1.4 Liposomes Drug Delivery Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Liposomes Drug Delivery in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Liposomes Drug Delivery Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Liposomes Drug Delivery Market Dynamics
1.5.1 Liposomes Drug Delivery Industry Trends
1.5.2 Liposomes Drug Delivery Market Drivers
1.5.3 Liposomes Drug Delivery Market Challenges
1.5.4 Liposomes Drug Delivery Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Liposomes Drug Delivery by Type
2.1 Liposomes Drug Delivery Market Segment by Type
2.1.1 Liposomal Doxorubicin
2.1.2 Liposomal Amphoteracin B
2.1.3 Liposomal Paclitaxel
2.1.4 Others
2.2 Global Liposomes Drug Delivery Market Size by Type
2.2.1 Global Liposomes Drug Delivery Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Liposomes Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Liposomes Drug Delivery Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Liposomes Drug Delivery Market Size by Type
2.3.1 India Liposomes Drug Delivery Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Liposomes Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Liposomes Drug Delivery Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Liposomes Drug Delivery by Application
3.1 Liposomes Drug Delivery Market Segment by Application
3.1.1 Fungal Infection Therapy
3.1.2 Cancer & Tumor Therapy
3.1.3 Others
3.2 Global Liposomes Drug Delivery Market Size by Application
3.2.1 Global Liposomes Drug Delivery Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Liposomes Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Liposomes Drug Delivery Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Liposomes Drug Delivery Market Size by Application
3.3.1 India Liposomes Drug Delivery Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Liposomes Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Liposomes Drug Delivery Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Liposomes Drug Delivery Competitor Landscape by Company
4.1 Global Liposomes Drug Delivery Market Size by Company
4.1.1 Global Key Manufacturers of Liposomes Drug Delivery, Ranked by Revenue (2022)
4.1.2 Global Liposomes Drug Delivery Revenue by Manufacturer (2018-2023)
4.1.3 Global Liposomes Drug Delivery Sales by Manufacturer (2018-2023)
4.1.4 Global Liposomes Drug Delivery Price by Manufacturer (2018-2023)
4.2 Global Liposomes Drug Delivery Concentration Ratio (CR)
4.2.1 Liposomes Drug Delivery Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Liposomes Drug Delivery in 2022
4.2.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Liposomes Drug Delivery, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Liposomes Drug Delivery, Product Offered and Application
4.5 Global Key Manufacturers of Liposomes Drug Delivery, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Liposomes Drug Delivery Market Size by Company
4.7.1 Key Players of Liposomes Drug Delivery in India, Ranked by Revenue (2022)
4.7.2 India Liposomes Drug Delivery Revenue by Players (2018-2023)
4.7.3 India Liposomes Drug Delivery Sales by Players (2018-2023)
5 Global Liposomes Drug Delivery Market Size by Region
5.1 Global Liposomes Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Liposomes Drug Delivery Market Size in Volume by Region (2018-2029)
5.2.1 Global Liposomes Drug Delivery Sales in Volume by Region: 2018-2023
5.2.2 Global Liposomes Drug Delivery Sales in Volume Forecast by Region (2024-2029)
5.3 Global Liposomes Drug Delivery Market Size in Value by Region (2018-2029)
5.3.1 Global Liposomes Drug Delivery Sales in Value by Region: 2018-2023
5.3.2 Global Liposomes Drug Delivery Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Liposomes Drug Delivery Market Size YoY Growth 2018-2029
6.2 Americas Liposomes Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Liposomes Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Liposomes Drug Delivery Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Liposomes Drug Delivery Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Liposomes Drug Delivery Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Liposomes Drug Delivery Market Size YoY Growth 2018-2029
7.2 EMEA Liposomes Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Liposomes Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Liposomes Drug Delivery Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Liposomes Drug Delivery Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Liposomes Drug Delivery Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Liposomes Drug Delivery Market Size YoY Growth 2018-2029
8.2 China Liposomes Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Liposomes Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Liposomes Drug Delivery Market Size YoY Growth 2018-2029
9.2 APAC Liposomes Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Liposomes Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Liposomes Drug Delivery Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Liposomes Drug Delivery Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Liposomes Drug Delivery Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Description and Business Overview
10.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Liposomes Drug Delivery Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Information
10.2.2 Gilead Sciences Description and Business Overview
10.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Gilead Sciences Liposomes Drug Delivery Products Offered
10.2.5 Gilead Sciences Recent Development
10.3 Pacira
10.3.1 Pacira Company Information
10.3.2 Pacira Description and Business Overview
10.3.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pacira Liposomes Drug Delivery Products Offered
10.3.5 Pacira Recent Development
10.4 Sun Pharmaceutical
10.4.1 Sun Pharmaceutical Company Information
10.4.2 Sun Pharmaceutical Description and Business Overview
10.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sun Pharmaceutical Liposomes Drug Delivery Products Offered
10.4.5 Sun Pharmaceutical Recent Development
10.5 Luye Pharma
10.5.1 Luye Pharma Company Information
10.5.2 Luye Pharma Description and Business Overview
10.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Luye Pharma Liposomes Drug Delivery Products Offered
10.5.5 Luye Pharma Recent Development
10.6 Sigma-Tau Group
10.6.1 Sigma-Tau Group Company Information
10.6.2 Sigma-Tau Group Description and Business Overview
10.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sigma-Tau Group Liposomes Drug Delivery Products Offered
10.6.5 Sigma-Tau Group Recent Development
10.7 Fudan-Zhangjiang
10.7.1 Fudan-Zhangjiang Company Information
10.7.2 Fudan-Zhangjiang Description and Business Overview
10.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Products Offered
10.7.5 Fudan-Zhangjiang Recent Development
10.8 Teva Pharmaceutical
10.8.1 Teva Pharmaceutical Company Information
10.8.2 Teva Pharmaceutical Description and Business Overview
10.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Teva Pharmaceutical Liposomes Drug Delivery Products Offered
10.8.5 Teva Pharmaceutical Recent Development
10.9 CSPC
10.9.1 CSPC Company Information
10.9.2 CSPC Description and Business Overview
10.9.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.9.4 CSPC Liposomes Drug Delivery Products Offered
10.9.5 CSPC Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Description and Business Overview
10.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis Liposomes Drug Delivery Products Offered
10.10.5 Novartis Recent Development
10.11 Kingond Pharm
10.11.1 Kingond Pharm Company Information
10.11.2 Kingond Pharm Description and Business Overview
10.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Kingond Pharm Liposomes Drug Delivery Products Offered
10.11.5 Kingond Pharm Recent Development
10.12 Spectrum Pharmaceuticals
10.12.1 Spectrum Pharmaceuticals Company Information
10.12.2 Spectrum Pharmaceuticals Description and Business Overview
10.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Products Offered
10.12.5 Spectrum Pharmaceuticals Recent Development
10.13 Shanghai New Asia
10.13.1 Shanghai New Asia Company Information
10.13.2 Shanghai New Asia Description and Business Overview
10.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Shanghai New Asia Liposomes Drug Delivery Products Offered
10.13.5 Shanghai New Asia Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Liposomes Drug Delivery Industry Chain Analysis
11.2 Liposomes Drug Delivery Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Liposomes Drug Delivery Production Mode & Process
11.4 Liposomes Drug Delivery Sales and Marketing
11.4.1 Liposomes Drug Delivery Sales Channels
11.4.2 Liposomes Drug Delivery Distributors
11.5 Liposomes Drug Delivery Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Carrier
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
List of Tables
    Table 1. Liposomes Drug Delivery CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Liposomes Drug Delivery Market Trends
    Table 3. Liposomes Drug Delivery Market Drivers
    Table 4. Liposomes Drug Delivery Market Challenges
    Table 5. Liposomes Drug Delivery Market Restraints
    Table 6. Global Liposomes Drug Delivery Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Liposomes Drug Delivery Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Liposomes Drug Delivery Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Liposomes Drug Delivery Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Liposomes Drug Delivery, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Liposomes Drug Delivery Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Liposomes Drug Delivery Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Liposomes Drug Delivery Sales by Manufacturer, (K Vials), 2018-2023
    Table 14. Global Liposomes Drug Delivery Sales Share by Manufacturer, 2018-2023
    Table 15. Global Liposomes Drug Delivery Price by Manufacturer (2018-2023) & (USD/Vial)
    Table 16. Global Liposomes Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2022)
    Table 18. Global Key Manufacturers of Liposomes Drug Delivery, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Liposomes Drug Delivery, Product Offered and Application
    Table 20. Global Key Manufacturers of Liposomes Drug Delivery, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Liposomes Drug Delivery in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Liposomes Drug Delivery Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Liposomes Drug Delivery Revenue Share by Players, (2018-2023)
    Table 25. India Liposomes Drug Delivery Sales by Players, (K Vials), (2018-2023)
    Table 26. India Liposomes Drug Delivery Sales Share by Players, (2018-2023)
    Table 27. Global Liposomes Drug Delivery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Liposomes Drug Delivery Sales in Volume by Region (2018-2023) & (K Vials)
    Table 29. Global Liposomes Drug Delivery Sales in Volume Forecast by Region (2024-2029) & (K Vials)
    Table 30. Global Liposomes Drug Delivery Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Liposomes Drug Delivery Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Liposomes Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Liposomes Drug Delivery Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Liposomes Drug Delivery Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Liposomes Drug Delivery Sales in Volume by Country (2018-2023) & (K Vials)
    Table 36. Americas Liposomes Drug Delivery Sales in Volume by Country (2024-2029) & (K Vials)
    Table 37. EMEA Liposomes Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Liposomes Drug Delivery Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Liposomes Drug Delivery Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Liposomes Drug Delivery Sales in Volume by Country (2018-2023) & (K Vials)
    Table 41. EMEA Liposomes Drug Delivery Sales in Volume by Country (2024-2029) & (K Vials)
    Table 42. APAC Liposomes Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Liposomes Drug Delivery Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Liposomes Drug Delivery Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Liposomes Drug Delivery Sales in Volume by Country (2018-2023) & (K Vials)
    Table 46. APAC Liposomes Drug Delivery Sales in Volume by Country (2024-2029) & (K Vials)
    Table 47. Johnson & Johnson Company Information
    Table 48. Johnson & Johnson Description and Business Overview
    Table 49. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 50. Johnson & Johnson Liposomes Drug Delivery Product
    Table 51. Johnson & Johnson Recent Development
    Table 52. Gilead Sciences Company Information
    Table 53. Gilead Sciences Description and Business Overview
    Table 54. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 55. Gilead Sciences Liposomes Drug Delivery Product
    Table 56. Gilead Sciences Recent Development
    Table 57. Pacira Company Information
    Table 58. Pacira Description and Business Overview
    Table 59. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 60. Pacira Liposomes Drug Delivery Product
    Table 61. Pacira Recent Development
    Table 62. Sun Pharmaceutical Company Information
    Table 63. Sun Pharmaceutical Description and Business Overview
    Table 64. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 65. Sun Pharmaceutical Liposomes Drug Delivery Product
    Table 66. Sun Pharmaceutical Recent Development
    Table 67. Luye Pharma Company Information
    Table 68. Luye Pharma Description and Business Overview
    Table 69. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 70. Luye Pharma Liposomes Drug Delivery Product
    Table 71. Luye Pharma Recent Development
    Table 72. Sigma-Tau Group Company Information
    Table 73. Sigma-Tau Group Description and Business Overview
    Table 74. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 75. Sigma-Tau Group Liposomes Drug Delivery Product
    Table 76. Sigma-Tau Group Recent Development
    Table 77. Fudan-Zhangjiang Company Information
    Table 78. Fudan-Zhangjiang Description and Business Overview
    Table 79. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 80. Fudan-Zhangjiang Liposomes Drug Delivery Product
    Table 81. Fudan-Zhangjiang Recent Development
    Table 82. Teva Pharmaceutical Company Information
    Table 83. Teva Pharmaceutical Description and Business Overview
    Table 84. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 85. Teva Pharmaceutical Liposomes Drug Delivery Product
    Table 86. Teva Pharmaceutical Recent Development
    Table 87. CSPC Company Information
    Table 88. CSPC Description and Business Overview
    Table 89. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 90. CSPC Liposomes Drug Delivery Product
    Table 91. CSPC Recent Development
    Table 92. Novartis Company Information
    Table 93. Novartis Description and Business Overview
    Table 94. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 95. Novartis Liposomes Drug Delivery Product
    Table 96. Novartis Recent Development
    Table 97. Kingond Pharm Company Information
    Table 98. Kingond Pharm Description and Business Overview
    Table 99. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 100. Kingond Pharm Liposomes Drug Delivery Product
    Table 101. Kingond Pharm Recent Development
    Table 102. Spectrum Pharmaceuticals Company Information
    Table 103. Spectrum Pharmaceuticals Description and Business Overview
    Table 104. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 105. Spectrum Pharmaceuticals Liposomes Drug Delivery Product
    Table 106. Spectrum Pharmaceuticals Recent Development
    Table 107. Shanghai New Asia Company Information
    Table 108. Shanghai New Asia Description and Business Overview
    Table 109. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 110. Shanghai New Asia Liposomes Drug Delivery Product
    Table 111. Shanghai New Asia Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Liposomes Drug Delivery Customers List
    Table 115. Liposomes Drug Delivery Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Liposomes Drug Delivery Product Picture
    Figure 2. Global Liposomes Drug Delivery Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Liposomes Drug Delivery Market Size 2018-2029 (US$ Million)
    Figure 4. Global Liposomes Drug Delivery Sales 2018-2029 (K Vials)
    Figure 5. India Liposomes Drug Delivery Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Liposomes Drug Delivery Market Size 2018-2029 (US$ Million)
    Figure 7. India Liposomes Drug Delivery Sales 2018-2029 (K Vials)
    Figure 8. India Liposomes Drug Delivery Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Liposomes Drug Delivery Market Share in Global, in Volume (K Vials) 2018-2029
    Figure 10. Liposomes Drug Delivery Report Years Considered
    Figure 11. Product Picture of Liposomal Doxorubicin
    Figure 12. Product Picture of Liposomal Amphoteracin B
    Figure 13. Product Picture of Liposomal Paclitaxel
    Figure 14. Product Picture of Others
    Figure 15. Global Liposomes Drug Delivery Market Share by Type in 2022 & 2029
    Figure 16. Global Liposomes Drug Delivery Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 17. Global Liposomes Drug Delivery Sales Market Share in Value by Type (2018-2029)
    Figure 18. Global Liposomes Drug Delivery Sales by Type (2018-2029) & (K Vials)
    Figure 19. Global Liposomes Drug Delivery Sales Market Share in Volume by Type (2018-2029)
    Figure 20. Global Liposomes Drug Delivery Price by Type (2018-2029) & (USD/Vial)
    Figure 21. India Liposomes Drug Delivery Market Share by Type in 2022 & 2029
    Figure 22. India Liposomes Drug Delivery Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 23. India Liposomes Drug Delivery Sales Market Share in Value by Type (2018-2029)
    Figure 24. India Liposomes Drug Delivery Sales by Type (2018-2029) & (K Vials)
    Figure 25. India Liposomes Drug Delivery Sales Market Share in Volume by Type (2018-2029)
    Figure 26. India Liposomes Drug Delivery Price by Type (2018-2029) & (USD/Vial)
    Figure 27. Product Picture of Fungal Infection Therapy
    Figure 28. Product Picture of Cancer & Tumor Therapy
    Figure 29. Product Picture of Others
    Figure 30. Global Liposomes Drug Delivery Market Share by Application in 2022 & 2029
    Figure 31. Global Liposomes Drug Delivery Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 32. Global Liposomes Drug Delivery Sales Market Share in Value by Application (2018-2029)
    Figure 33. Global Liposomes Drug Delivery Sales by Application (2018-2029) & (K Vials)
    Figure 34. Global Liposomes Drug Delivery Sales Market Share in Volume by Application (2018-2029)
    Figure 35. Global Liposomes Drug Delivery Price by Application (2018-2029) & (USD/Vial)
    Figure 36. India Liposomes Drug Delivery Market Share by Application in 2022 & 2029
    Figure 37. India Liposomes Drug Delivery Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 38. India Liposomes Drug Delivery Sales Market Share in Value by Application (2018-2029)
    Figure 39. India Liposomes Drug Delivery Sales by Application (2018-2029) & (K Vials)
    Figure 40. India Liposomes Drug Delivery Sales Market Share in Volume by Application (2018-2029)
    Figure 41. India Liposomes Drug Delivery Price by Application (2018-2029) & (USD/Vial)
    Figure 42. Americas Liposomes Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 43. Americas Liposomes Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 44. Americas Liposomes Drug Delivery Sales by Type (2018-2029) & (K Vials)
    Figure 45. Americas Liposomes Drug Delivery Sales Market Share in Volume by Type (2018-2029)
    Figure 46. Americas Liposomes Drug Delivery Sales by Application (2018-2029) & (K Vials)
    Figure 47. Americas Liposomes Drug Delivery Sales Market Share in Volume by Application (2018-2029)
    Figure 48. United States Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Canada Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Mexico Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. EMEA Liposomes Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 53. EMEA Liposomes Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 54. EMEA Liposomes Drug Delivery Sales by Type (2018-2029) & (K Vials)
    Figure 55. EMEA Liposomes Drug Delivery Sales Market Share in Volume by Type (2018-2029)
    Figure 56. EMEA Liposomes Drug Delivery Sales by Application (2018-2029) & (K Vials)
    Figure 57. EMEA Liposomes Drug Delivery Sales Market Share in Volume by Application (2018-2029)
    Figure 58. Europe Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Middle East Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Africa Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. China Liposomes Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 62. China Liposomes Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 63. China Liposomes Drug Delivery Sales by Type (2018-2029) & (K Vials)
    Figure 64. China Liposomes Drug Delivery Sales Market Share in Volume by Type (2018-2029)
    Figure 65. China Liposomes Drug Delivery Sales by Application (2018-2029) & (K Vials)
    Figure 66. China Liposomes Drug Delivery Sales Market Share in Volume by Application (2018-2029)
    Figure 67. APAC Liposomes Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 68. APAC Liposomes Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 69. APAC Liposomes Drug Delivery Sales by Type (2018-2029) & (K Vials)
    Figure 70. APAC Liposomes Drug Delivery Sales Market Share in Volume by Type (2018-2029)
    Figure 71. APAC Liposomes Drug Delivery Sales by Application (2018-2029) & (K Vials)
    Figure 72. APAC Liposomes Drug Delivery Sales Market Share in Volume by Application (2018-2029)
    Figure 73. Japan Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. South Korea Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. China Taiwan Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Southeast Asia Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. India Liposomes Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. Liposomes Drug Delivery Value Chain
    Figure 79. Liposomes Drug Delivery Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$4350

Single User License
Electronic

$6525

Multi User License
Electronic

$8700

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions